FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997788346> ?p ?o ?g. }

• W1997788346 endingPage "e62334" @default.
• W1997788346 startingPage "e62334" @default.
• W1997788346 abstract "Introduction The role of miRNAs in acquired endocrine-resistant breast cancer is not fully understood. One hallmark of tumor progression is epithelial-to-mesenchymal transition (EMT), characterized by a loss of cell adhesion resulting from reduced E-cadherin and increased cell mobility. miR-200 family members regulate EMT by suppressing expression of transcriptional repressors ZEB1/2. Previously we reported that the expression of miR-200a, miR-200b, and miR-200c was lower in LY2 endocrine-resistant, mesenchymal breast cancer cells compared to parental, endocrine sensitive, epithelial MCF-7 breast cancer cells. Here we investigated the regulation of miR-200 family members and their role in endocrine-sensitivity in breast cancer cells. Results miR-200 family expression was progressively reduced in a breast cancer cell line model of advancing endocrine/tamoxifen (TAM) resistance. Concomitant with miR-200 decrease, there was an increase in ZEB1 mRNA expression. Overexpression of miR-200b or miR-200c in LY2 cells altered cell morphology to a more epithelial appearance and inhibited cell migration. Further, miR-200b and miR-200c overexpression sensitized LY2 cells to growth inhibition by estrogen receptor (ER) antagonists TAM and fulvestrant. Knockdown of ZEB1 in LY2 cells recapitulated the effect of miR-200b and miR-200c overexpression resulting in inhibition of LY2 cell proliferation by TAM and fulvestrant, but not the aromatase inhibitor exemestane. Demethylating agent 5-aza-2′-deoxycytidine (5-aza-dC) in combination with histone deacetylase inhibitor trichostatin A (TSA) increased miR-200b and miR-200c in LY2 cells. Concomitant with the increase in miR-200b and miR-200c, ZEB1 expression was decreased and cells appeared more epithelial in morphology and were sensitized to TAM and fulvestrant inhibition. Likewise, knockdown of ZEB1 increased antiestrogen sensitivity of LY2 cells resulting in inhibition of cell proliferation. Conclusions Our data indicate that reduced miRNA-200b and miR-200c expression contributes to endocrine resistance in breast cancer cells and that the reduced expression of these miR-200 family members in endocrine-resistant cells can be reversed by 5-aza-dC+TSA." @default.
• W1997788346 created "2016-06-24" @default.
• W1997788346 creator A5002140834 @default.
• W1997788346 creator A5015053116 @default.
• W1997788346 creator A5070981762 @default.
• W1997788346 creator A5071748010 @default.
• W1997788346 creator A5078066178 @default.
• W1997788346 creator A5081153905 @default.
• W1997788346 date "2013-04-23" @default.
• W1997788346 modified "2023-09-24" @default.
• W1997788346 title "Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells" @default.
• W1997788346 cites W1964081206 @default.
• W1997788346 cites W1964287896 @default.
• W1997788346 cites W1964314383 @default.
• W1997788346 cites W1965882417 @default.
• W1997788346 cites W1972011114 @default.
• W1997788346 cites W1973281089 @default.
• W1997788346 cites W1976324983 @default.
• W1997788346 cites W1978629545 @default.
• W1997788346 cites W1979067350 @default.
• W1997788346 cites W1979333273 @default.
• W1997788346 cites W1983991097 @default.
• W1997788346 cites W1985055097 @default.
• W1997788346 cites W1992968941 @default.
• W1997788346 cites W1996350041 @default.
• W1997788346 cites W2004102172 @default.
• W1997788346 cites W2011244990 @default.
• W1997788346 cites W2014442719 @default.
• W1997788346 cites W2017333359 @default.
• W1997788346 cites W2017905687 @default.
• W1997788346 cites W2022102157 @default.
• W1997788346 cites W2022770843 @default.
• W1997788346 cites W2022916389 @default.
• W1997788346 cites W2025005089 @default.
• W1997788346 cites W2025647419 @default.
• W1997788346 cites W2035255090 @default.
• W1997788346 cites W2036801235 @default.
• W1997788346 cites W2045792003 @default.
• W1997788346 cites W2048910343 @default.
• W1997788346 cites W2049048085 @default.
• W1997788346 cites W2049839607 @default.
• W1997788346 cites W2053005267 @default.
• W1997788346 cites W2056746270 @default.
• W1997788346 cites W2058126188 @default.
• W1997788346 cites W2059080364 @default.
• W1997788346 cites W2062954242 @default.
• W1997788346 cites W2066419333 @default.
• W1997788346 cites W2069266255 @default.
• W1997788346 cites W2069588389 @default.
• W1997788346 cites W2070058781 @default.
• W1997788346 cites W2070317848 @default.
• W1997788346 cites W2087367170 @default.
• W1997788346 cites W2093402539 @default.
• W1997788346 cites W2097951173 @default.
• W1997788346 cites W2103333909 @default.
• W1997788346 cites W2109190015 @default.
• W1997788346 cites W2109388713 @default.
• W1997788346 cites W2112666597 @default.
• W1997788346 cites W2118204028 @default.
• W1997788346 cites W2122725298 @default.
• W1997788346 cites W2125120607 @default.
• W1997788346 cites W2126741228 @default.
• W1997788346 cites W2131722060 @default.
• W1997788346 cites W2135891897 @default.
• W1997788346 cites W2138885372 @default.
• W1997788346 cites W2140551998 @default.
• W1997788346 cites W2141232624 @default.
• W1997788346 cites W2143825101 @default.
• W1997788346 cites W2149880040 @default.
• W1997788346 cites W2155131748 @default.
• W1997788346 cites W2164484108 @default.
• W1997788346 cites W2168215039 @default.
• W1997788346 cites W4237473415 @default.
• W1997788346 doi "https://doi.org/10.1371/journal.pone.0062334" @default.
• W1997788346 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3633860" @default.
• W1997788346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23626803" @default.
• W1997788346 hasPublicationYear "2013" @default.
• W1997788346 type Work @default.
• W1997788346 sameAs 1997788346 @default.
• W1997788346 citedByCount "88" @default.
• W1997788346 countsByYear W19977883462013 @default.
• W1997788346 countsByYear W19977883462014 @default.
• W1997788346 countsByYear W19977883462015 @default.
• W1997788346 countsByYear W19977883462016 @default.
• W1997788346 countsByYear W19977883462017 @default.
• W1997788346 countsByYear W19977883462018 @default.
• W1997788346 countsByYear W19977883462019 @default.
• W1997788346 countsByYear W19977883462020 @default.
• W1997788346 countsByYear W19977883462021 @default.
• W1997788346 countsByYear W19977883462022 @default.
• W1997788346 countsByYear W19977883462023 @default.
• W1997788346 crossrefType "journal-article" @default.
• W1997788346 hasAuthorship W1997788346A5002140834 @default.
• W1997788346 hasAuthorship W1997788346A5015053116 @default.
• W1997788346 hasAuthorship W1997788346A5070981762 @default.
• W1997788346 hasAuthorship W1997788346A5071748010 @default.
• W1997788346 hasAuthorship W1997788346A5078066178 @default.
• W1997788346 hasAuthorship W1997788346A5081153905 @default.

• next